Direct comparison
R01 vs. R21: NIH Grant Mechanisms Compared
R01 is NIH's standard multi-year research grant needing preliminary data; R21 is a 2-year, $275K-capped exploratory grant that doesn't. Compare both.
Side-by-side comparison
| Dimension | R01 (Research Project Grant) | R21 (Exploratory/Developmental Grant) |
|---|---|---|
| Purpose | Fund a discrete, already-de-risked research project chosen and defined by the investigator | Fund early-stage, high-risk exploratory or developmental work — testing a novel idea, model, or tool |
| Preliminary data | Typically expected — substantial preliminary data is standard for a competitive application | Most FOAs explicitly do not require it — the mechanism's defining feature relative to R01 |
| Project period | Commonly up to 5 years (varies by FOA) | No more than 2 years, NIH-wide |
| Budget cap | No fixed NIH-wide cap; modular budget available up to $250,000 direct costs/year | $275,000 total direct costs over the project period; no more than $200,000 in any single year |
| Renewal | Eligible for competing renewal (Type 2 application) | No renewal mechanism — a new award is required after the project period ends |
| Standard due dates (new applications) | February 5, June 5, October 5 | February 16, June 16, October 16 |
| Instrument type | Grant — Federal Grant and Cooperative Agreement Act, 31 U.S.C. § 6304 | Grant — same statute; not a cooperative agreement |
| Can pair with a phase-two mechanism | No equivalent phased structure | Yes — can be paired with R33 as a milestone-gated “R21/R33” two-phase award |
Common questions
FAQ
Can I apply for an R21 and then follow it with an R01?+
Yes, and it's a common sequencing strategy: an R21 can generate the feasibility evidence and initial data that later support a competitive R01 application on the same research direction. NIH does not formally link the two mechanisms or guarantee that progression — the follow-on R01 is a fresh, independently reviewed application.
Is R21 easier to get than R01?+
Not necessarily easier, but different: R21 doesn't require the preliminary data an R01 study section typically expects, which can make it more accessible for a genuinely early-stage idea. Payline and success rates vary by NIH Institute and fiscal year for both mechanisms; R21 is not a guaranteed easier path, just a differently-scoped one suited to higher-risk, less-developed work.
Can an R21 be renewed like an R01?+
No. R21 has no competing renewal (Type 2) mechanism. When the two-year project period ends, the PI must pursue a new award — a new R21, a follow-on R01, or, where the FOA offers it, a transition into a paired R33 development phase.
Do R01 and R21 use the same budget format?+
Both are eligible for NIH's simplified modular budget when direct costs stay at or under $250,000/year, which in practice covers essentially all R21s (capped at $200,000/year) and many R01s. R01s requesting above that threshold use a detailed, non-modular budget instead.
Going deeper
